These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38888319)

  • 21. Antibiotics cure anthrax in animal models.
    Weiss S; Kobiler D; Levy H; Pass A; Ophir Y; Rothschild N; Tal A; Schlomovitz J; Altboum Z
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1533-42. PubMed ID: 21263056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.
    Mytle N; Hopkins RJ; Malkevich NV; Basu S; Meister GT; Sanford DC; Comer JE; Van Zandt KE; Al-Ibrahim M; Kramer WG; Howard C; Daczkowski N; Chakrabarti AC; Ionin B; Nabors GS; Skiadopoulos MH
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5684-92. PubMed ID: 23979731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative pre-approved and novel therapies for the treatment of anthrax.
    Head BM; Rubinstein E; Meyers AF
    BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
    Crandon JL; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5115-9. PubMed ID: 20837760
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Martchenko Shilman M; Bartolo G; Alameh S; Peterson JW; Lawrence WS; Peel JE; Sivasubramani SK; Beasley DWC; Cote CK; Demons ST; Halasahoris SA; Miller LL; Klimko CP; Shoe JL; Fetterer DP; McComb R; Ho CC; Bradley KA; Hartmann S; Cheng LW; Chugunova M; Kao CY; Tran JK; Derbedrossian A; Zilbermintz L; Amali-Adekwu E; Levitin A; West J
    ACS Infect Dis; 2021 Aug; 7(8):2176-2191. PubMed ID: 34218660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.
    Migone TS; Bolmer S; Zhong J; Corey A; Vasconcelos D; Buccellato M; Meister G
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1145-51. PubMed ID: 25487792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective antiprotease-antibiotic treatment of experimental anthrax.
    Popov SG; Popova TG; Hopkins S; Weinstein RS; MacAfee R; Fryxell KJ; Chandhoke V; Bailey C; Alibek K
    BMC Infect Dis; 2005 Apr; 5():25. PubMed ID: 15819985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis.
    Sittner A; Ben-Shmuel A; Glinert I; Bar-David E; Schlomovitz J; Kobiler D; Weiss S; Levy H
    PLoS One; 2020; 15(2):e0228917. PubMed ID: 32053632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of
    Manzulli V; Fasanella A; Parisi A; Serrecchia L; Donatiello A; Rondinone V; Caruso M; Zange S; Tscherne A; Decaro N; Pedarra C; Galante D
    J Vet Sci; 2019 Jan; 20(1):58-62. PubMed ID: 30541185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to antibiotics of Bacillus anthracis strains isolated in Romania.
    Caplan DM; Ivana S; Caplan ME
    Roum Arch Microbiol Immunol; 2009; 68(2):106-10. PubMed ID: 20361530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
    Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
    Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
    Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacillus anthracis infections--new possibilities of treatment.
    Żakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Knap J; Cieślik P; Chomiczewski K; Kocik J
    Ann Agric Environ Med; 2015; 22(2):202-7. PubMed ID: 26094508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients.
    Roch M; Varela MC; Taglialegna A; Rose WE; Rosato AE
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates.
    Drago L; De Vecchi E; Lombardi A; Nicola L; Valli M; Gismondo MR
    J Antimicrob Chemother; 2002 Dec; 50(6):1059-63. PubMed ID: 12461034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacillus anthracis and antibacterial agents.
    Bryskier A
    Clin Microbiol Infect; 2002 Aug; 8(8):467-78. PubMed ID: 12197869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis.
    McCurdy S; Halasohoris SA; Babyak AL; Lembirik S; Hoover R; Hickman M; Scarff J; Klimko CP; Cote CK; Meinig JM
    J Antimicrob Chemother; 2023 Mar; 78(3):810-816. PubMed ID: 36738250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.
    Slay RM; Hewitt JA; Crumrine M
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S411-S416. PubMed ID: 36251550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
    Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2383-8. PubMed ID: 18443115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.